Columnist

Steven Syre

Syre writes about local business, economics, and markets twice weekly in the Globe’s Boston Capital column. He joined the Globe in 1995 and previously wrote a financial column in the Boston Herald.

Latest stories

Steven Syre | Boston Capital

Nuance Communications one of nine US companies to flunk ‘say on pay’

By , Globe Staff

To hunt for evidence of really audacious pay packages, take a look at how stockholders vote on the subject.

Steven Syre

High prices for drugs to treat rare diseases take a toll

By , Globe Staff

Worldwide sales of orphan drugs amounted to less than $20 billion in 2000, but by 2020 are forecast to cost $176 billion.

Steven Syre | Boston Capital

New viewing options challenge future of cable TV giants

By , Globe Staff

TV may not necessarily become cheaper, but you shouldn’t have to pay for content you don’t want.

Steven Syre | Boston Capital

Patent crusade benefits whom?

By , Globe Staff

Hedge fund manager Kyle Bass has been challenging the patents that drug companies hold for some of their most lucrative medicines.